Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
40.6K
-
Shares change
-
-25.4K
-
Total reported value, excl. options
-
$72.3K
-
Value change
-
-$45.3K
-
Number of sells
-
-1
-
Price
-
$1.78
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q4 2023
2 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q4 2023.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.6K shares
of 130M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (11.2M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.87M shares), VANGUARD GROUP INC (2.9M shares), BlackRock Inc. (2.87M shares), Bleichroeder LP (2M shares), Brown University (1M shares), STATE STREET CORP (981K shares), GEODE CAPITAL MANAGEMENT, LLC (899K shares), BANK OF AMERICA CORP /DE/ (655K shares), and MILLENNIUM MANAGEMENT LLC (638K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.